ÀÖ²¥´«Ã½app×îа汾

In 2024, the pharmaceutical industry spent almost 15 percent of its research and development investments during pre-human or pre-clinical stages. Meanwhile, the industry spent about 45 percent of its R&D investments on clinical trials.